How Can We Help You?

Insights

Dr. Anton C. Bizzell shares his insights in the Verywell Health article, “Regeneron Earns First-Ever FDA Approval For Ebola Treatment,” about the U.S. Food and Drug Administration (FDA) approval of Inmazeb, an antibody cocktail designed to...
In a recent Psychology Today article, Dr. Anton C. Bizzell highlights some of the lessons The Bizzell Group (Bizzell) learned during the most recent Ebola virus epidemic. Bizzell partnered with...
Dr. Bizzell’s behavioral health expertise is highlighted in his recent article in the Behavioral Healthcare Executive, “Strategic Approach to Care Coordination Drives Better Outcomes in ER.” While coordinating this...
Dr. Bizzell shares his journey from physician to a businessman in a new Washington Business Journal series, "My Story," in which business executives share their personal and professional backgrounds and journeys, their challenges, and their successes.
As symptoms of stress, anxiety, and depression are increasing during the global COVID-19 pandemic, people may be exploring technology-based strategies to relieve...
The global COVID-19 pandemic has had profound social, economic, and health effects. A recent study found that 56% of U.S. adults reported that worry or stress related to the pandemic has caused them to...
Alcohol use disorder (AUD) is often referred to as the hidden substance use disorder (SUD). With alcohol use legal and socially acceptable in many settings...
The opioid crisis has a complex set of contributing factors in women...
The National Center for PTSD promotes awareness of PTSD and effective treatments throughout the year. Starting in 2010, Congress named June 27th PTSD Awareness Day.